A detailed history of Bdf Gestion transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bdf Gestion holds 40,742 shares of BMY stock, worth $2.03 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
40,742
Holding current value
$2.03 Million
% of portfolio
0.16%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

BUY
$40.25 - $52.99 $1.64 Million - $2.16 Million
40,742 New
40,742 $1.69 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $106B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Bdf Gestion Portfolio

Follow Bdf Gestion and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bdf Gestion, based on Form 13F filings with the SEC.

News

Stay updated on Bdf Gestion with notifications on news.